Dr. Rosenberg Spreads Sleep Awareness Throughout the Country

December 13, 2010

Dr. Russell Rosenberg, CEO of NeuroTrials Research & Vice Chair of the National Sleep Foundation, will be representing the National Sleep Foundation tomorrow in a series of radio interviews about sleep and work performance.

In addition to discussing the impact of sleep on work performance, Dr. Rosenberg will also cover tips to get a better night’s sleep and how to wake up feeling refreshed and energized.

On the national level, you can catch Dr. Rosenberg on the USA Radio Network at 7:10 AM, CRN Network at 10:30 AM, and Health Radio Network from 12:15-12:30.

Dr. Rosenberg will also be interviewed by stations in Boston, Orlando, Hartford, Minneapolis, Cleveland, Los Angeles, Colorado, Kansas, & Seattle.

Tune in tomorrow, December 14, for more!

Advertisements

Alzheimer’s First-Time Inclusion in National Public Health Report

December 8, 2010

For the first time since its creation in 1979, the government’s report on health objectives and goals over the next decade includes Alzheimer’s disease. Known as Healthy People 2020, the report was developed through a broad consultation process and built on the best scientific knowledge available.  It is designed to be used by states, communities, professional organizations, and others to assit in developing programs that improve our nation’s health. 

Alzheimer’s is the sixth-leading cause of death in our nation and more than 5 million Americans are currently diagnosed with the disease. Because the risk of Alzheimer’s expands with age, as many as 16 million Americans are expected to be diagnosed with Alzheimer’s by 2050. With goals set through Healthy People 2020, many are hoping that projection will decrease.

The report includes objectives such as increasing education about the disease and increasing the awareness of the diagnosis to those with Alzeheimer’s or their caregivers. According to the American Alzheimer’s Association, fewer than half of patients with Alzheimer’s have the diagnosis listed on their medical records.

Healthy People 2020 also establishes a goal of reducing the number of preventable hospitalizations for those with  Alzheimer’s by preventing the conditions that cause admittance and optimizing outpatient care.

If you or someone you know has been diagnosed with Alzheimer’s disease, and live near the Atlanta area, consider participating in NeuroTrials Research’s clinical research study. We are currently evaulating an investigational drug for Alzheimer’s. You may be eligible to participate if you are 50 years or older and have a diagnosis of mild to moderate Alzheimer’s. For more information visit our studies page or call us at (404) 851-9934.

Why Participate in A Clinical Trial?
According to the national Alzheimer’s Association, “through clinical trials, researchers test new ways to detect, treat and prevent Alzheimer’s disease and related dementias. Without clinical trials, there can be no new treatments or cures. Over the last 15 years, scientists have made enormous strides in understanding how Alzheimer’s disease affects the brain. Scientists believe that in the near future, therapies and treatments that slow or stop the progression of the disease will be available.Ground-breaking research is going on that could have a measurable impact on the lives of current and future Alzheimer patients. Participation in clinical studies provides an opportunity to advance and accelerate medical research and to contribute to the better health of future generations.”